Lantheus Holdings, Inc. Stock-Based Compensation
Lantheus Holdings, Inc. (LNTH) reported Stock-Based Compensation of $36.05 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-06
- Lantheus Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $20.01M, a 10.37% decline year-over-year.
- Lantheus Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $16.04M, a 24.33% decline year-over-year.
- Lantheus Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $17.54M, a 20.85% decline year-over-year.
- Lantheus Holdings, Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $24.50M, a 20.30% increase year-over-year.
- Lantheus Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $85.56M, a 12.00% increase from fiscal 2024.
- Lantheus Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $76.39M, a 51.25% increase from fiscal 2023.
- Lantheus Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $50.51M, a 72.60% increase from fiscal 2022.
- Lantheus Holdings, Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $29.26M, a 83.65% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $20.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $36.05M 10-Q · filed 2026-08-06 | $53.59M derived: sum of 3 quarters · filed 2026-08-06 | $78.09M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $16.04M 10-Q · filed 2026-05-07 | $33.58M derived: sum of 2 quarters · filed 2026-05-07 | $58.09M derived: sum of 3 quarters · filed 2026-05-07 | $80.41M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $17.54M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.04M derived: sum of 2 quarters · filed 2026-02-26 | $64.36M derived: sum of 3 quarters · filed 2026-08-06 | $85.56M 10-K · filed 2026-02-26 |
| 2025-09-30 | $24.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $46.82M derived: sum of 2 quarters · filed 2026-08-06 | $68.02M 10-Q · filed 2025-11-06 | $90.18M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $22.32M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $43.52M 10-Q · filed 2026-08-06 | $65.68M derived: sum of 3 quarters · filed 2026-08-06 | $86.05M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $21.20M 10-Q · filed 2026-05-07 | $43.36M derived: sum of 2 quarters · filed 2026-05-07 | $63.73M derived: sum of 3 quarters · filed 2026-05-07 | $82.21M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $22.16M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $42.53M derived: sum of 2 quarters · filed 2026-02-26 | $61.01M derived: sum of 3 quarters · filed 2026-02-26 | $76.39M 10-K · filed 2026-02-26 |
| 2024-09-30 | $20.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-06 | $38.84M derived: sum of 2 quarters · filed 2025-11-06 | $54.23M 10-Q · filed 2025-11-06 | $68.40M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $18.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-06 | $33.86M 10-Q · filed 2025-08-06 | $48.03M derived: sum of 3 quarters · filed 2026-02-26 | $62.01M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $15.38M 10-Q · filed 2025-05-07 | $29.56M derived: sum of 2 quarters · filed 2026-02-26 | $43.53M derived: sum of 3 quarters · filed 2026-02-26 | $56.22M derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $14.17M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $28.15M derived: sum of 2 quarters · filed 2026-02-26 | $40.84M derived: sum of 3 quarters · filed 2026-02-26 | $50.51M 10-K · filed 2026-02-26 |
| 2023-09-30 | $13.98M 10-Q · filed 2023-11-02 | $26.67M derived: sum of 2 quarters · filed 2023-11-02 | $36.34M 10-Q · filed 2024-11-06 | $44.46M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-06-30 | $12.69M 10-Q · filed 2023-08-03 | $22.36M 10-Q · filed 2024-07-31 | $30.48M derived: sum of 3 quarters · filed 2025-02-26 | $38.59M derived: sum of 4 quarters · filed 2025-02-26 |
| 2023-03-31 | $9.67M 10-Q · filed 2024-05-02 | $17.79M derived: sum of 2 quarters · filed 2025-02-26 | $25.89M derived: sum of 3 quarters · filed 2025-02-26 | $33.31M derived: sum of 4 quarters · filed 2025-02-26 |
| 2022-12-31 | $8.12M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-26 | $16.23M derived: sum of 2 quarters · filed 2025-02-26 | $23.64M derived: sum of 3 quarters · filed 2025-02-26 | $29.26M 10-K · filed 2025-02-26 |
| 2022-09-30 | $8.10M 10-Q · filed 2023-11-02 | $15.52M derived: sum of 2 quarters · filed 2023-11-02 | $21.14M 10-Q · filed 2023-11-02 | $25.30M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-06-30 | $7.41M 10-Q · filed 2023-08-03 | $13.04M 10-Q · filed 2023-08-03 | $17.20M derived: sum of 3 quarters · filed 2024-02-22 | $21.06M derived: sum of 4 quarters · filed 2024-02-22 |
| 2022-03-31 | $5.62M 10-Q · filed 2023-05-04 | $9.79M derived: sum of 2 quarters · filed 2024-02-22 | $13.65M derived: sum of 3 quarters · filed 2024-02-22 | $18.24M derived: sum of 4 quarters · filed 2024-02-22 |
| 2021-12-31 | $4.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-22 | $8.03M derived: sum of 2 quarters · filed 2024-02-22 | $12.62M derived: sum of 3 quarters · filed 2024-02-22 | $15.93M 10-K · filed 2024-02-22 |
| 2021-09-30 | $3.87M 10-Q · filed 2022-11-03 | $8.46M derived: sum of 2 quarters · filed 2022-11-03 | $11.77M 10-Q · filed 2022-11-03 | $15.39M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-06-30 | $4.59M 10-Q · filed 2022-08-04 | $7.91M 10-Q · filed 2022-08-04 | $11.53M derived: sum of 3 quarters · filed 2023-02-23 | $15.52M derived: sum of 4 quarters · filed 2023-02-23 |
| 2021-03-31 | $3.32M 10-Q · filed 2022-04-29 | $6.94M derived: sum of 2 quarters · filed 2023-02-23 | $10.93M derived: sum of 3 quarters · filed 2023-02-23 | $14.32M derived: sum of 4 quarters · filed 2023-02-23 |
| 2020-12-31 | $3.62M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-23 | $7.62M derived: sum of 2 quarters · filed 2023-02-23 | $11.00M derived: sum of 3 quarters · filed 2023-02-23 | $14.07M 10-K · filed 2023-02-23 |
| 2020-09-30 | $3.99M 10-Q · filed 2021-11-04 | $7.38M derived: sum of 2 quarters · filed 2021-11-04 | $10.45M 10-Q · filed 2021-11-04 | $13.44M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $3.38M 10-Q · filed 2021-07-28 | $6.46M 10-Q · filed 2021-07-28 | $9.45M derived: sum of 3 quarters · filed 2022-02-24 | $12.87M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $3.08M 10-Q · filed 2021-05-04 | $6.07M derived: sum of 2 quarters · filed 2022-02-24 | $9.49M derived: sum of 3 quarters · filed 2022-02-24 | $12.85M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $2.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24 | $6.41M derived: sum of 2 quarters · filed 2022-02-24 | $9.77M derived: sum of 3 quarters · filed 2022-02-24 | $12.49M 10-K · filed 2022-02-24 |
| 2019-09-30 | $3.42M 10-Q · filed 2020-11-05 | $6.78M derived: sum of 2 quarters · filed 2020-11-05 | $9.50M 10-Q · filed 2020-11-05 | $11.80M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $3.36M 10-Q · filed 2020-07-31 | $6.08M 10-Q · filed 2020-07-31 | $8.38M derived: sum of 3 quarters · filed 2021-02-25 | $10.78M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.72M 10-Q · filed 2020-04-30 | $5.02M derived: sum of 2 quarters · filed 2021-02-25 | $7.43M derived: sum of 3 quarters · filed 2021-02-25 | $9.64M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $4.71M derived: sum of 2 quarters · filed 2021-02-25 | $6.92M derived: sum of 3 quarters · filed 2021-02-25 | $8.72M 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.41M 10-Q · filed 2019-10-31 | $4.62M derived: sum of 2 quarters · filed 2019-10-31 | $6.42M 10-Q · filed 2019-10-31 | $8.58M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-06-30 | $2.22M 10-Q · filed 2019-07-25 | $4.01M 10-Q · filed 2019-07-25 | $6.18M derived: sum of 3 quarters · filed 2020-02-25 | $7.83M derived: sum of 4 quarters · filed 2020-02-25 |
| 2018-03-31 | $1.80M 10-Q · filed 2019-04-30 | $3.96M derived: sum of 2 quarters · filed 2020-02-25 | $5.62M derived: sum of 3 quarters · filed 2020-02-25 | $6.78M derived: sum of 4 quarters · filed 2020-02-25 |
| 2017-12-31 | $2.16M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25 | $3.82M derived: sum of 2 quarters · filed 2020-02-25 | $4.98M derived: sum of 3 quarters · filed 2020-02-25 | $5.93M 10-K · filed 2020-02-25 |
| 2017-09-30 | $1.66M 10-Q · filed 2018-10-30 | $2.82M derived: sum of 2 quarters · filed 2018-10-30 | $3.76M 10-Q · filed 2018-10-30 | $4.42M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-06-30 | $1.16M 10-Q · filed 2018-08-01 | $2.11M 10-Q · filed 2018-08-01 | $2.76M derived: sum of 3 quarters · filed 2019-02-20 | $3.64M derived: sum of 4 quarters · filed 2019-02-20 |
| 2017-03-31 | $945.00K 10-Q · filed 2018-05-02 | $1.60M derived: sum of 2 quarters · filed 2019-02-20 | $2.48M derived: sum of 3 quarters · filed 2019-02-20 | $3.06M derived: sum of 4 quarters · filed 2019-02-20 |
| 2016-12-31 | $655.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | $1.53M derived: sum of 2 quarters · filed 2019-02-20 | $2.12M derived: sum of 3 quarters · filed 2019-02-20 | $2.52M 10-K · filed 2019-02-20 |
| 2016-09-30 | $877.00K 10-Q · filed 2017-11-02 | $1.46M derived: sum of 2 quarters · filed 2017-08-01 | $1.87M 10-Q · filed 2017-11-02 | $2.35M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-06-30 | $585.00K 10-Q · filed 2017-08-01 | $992.00K 10-Q · filed 2017-08-01 | $1.47M derived: sum of 3 quarters · filed 2018-02-26 | $2.06M derived: sum of 4 quarters · filed 2018-02-26 |
| 2016-03-31 | $407.00K 10-Q · filed 2017-05-02 | $885.00K derived: sum of 2 quarters · filed 2018-02-26 | $1.48M derived: sum of 3 quarters · filed 2018-02-26 | $2.13M derived: sum of 4 quarters · filed 2018-02-26 |
| 2015-12-31 | $478.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26 | $1.07M derived: sum of 2 quarters · filed 2018-02-26 | $1.73M derived: sum of 3 quarters · filed 2018-02-26 | $2.00M 10-K · filed 2018-02-26 |
| 2015-09-30 | $591.00K 10-Q · filed 2016-11-01 | $1.25M derived: sum of 2 quarters · filed 2016-11-01 | $1.52M 10-Q · filed 2016-11-01 | $1.77M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-06-30 | $656.00K 10-Q · filed 2016-08-04 | $933.00K 10-Q · filed 2016-08-04 | $1.18M derived: sum of 3 quarters · filed 2017-02-23 | $1.43M derived: sum of 4 quarters · filed 2017-02-23 |
| 2015-03-31 | $277.00K 10-Q · filed 2016-05-03 | $526.00K derived: sum of 2 quarters · filed 2017-02-23 | $773.00K derived: sum of 3 quarters · filed 2017-02-23 | $1.02M derived: sum of 4 quarters · filed 2017-02-23 |
| 2014-12-31 | $249.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-23 | $496.00K derived: sum of 2 quarters · filed 2017-02-23 | $747.00K derived: sum of 3 quarters · filed 2017-02-23 | $1.03M 10-K · filed 2017-02-23 |
| 2014-09-30 | $247.00K 10-Q · filed 2015-11-04 | $498.00K derived: sum of 2 quarters · filed 2015-11-04 | $782.00K 10-Q · filed 2015-11-04 | |
| 2014-06-30 | $251.00K 10-Q · filed 2015-08-05 | $535.00K 10-Q · filed 2015-08-05 | ||
| 2013-12-31 | $578.00K 10-K · filed 2016-03-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B |